Pharmacological management of invasive mold infections in solid organ transplant recipients

Mario Fernández-Ruiz
DOI: https://doi.org/10.1080/14656566.2024.2326507
2024-03-13
Expert Opinion on Pharmacotherapy
Abstract:Introduction Solid organ transplant (SOT) recipients face an increased susceptibility to invasive fungal infection (IFI) due to filamentous fungi. Post-transplant invasive aspergillosis (IA) and mucormycosis are related to exceedingly high mortality rates and graft loss risk, and its management involve a unique range of clinical challenges.
pharmacology & pharmacy
What problem does this paper attempt to address?